Fibrosis-4 and NAFLD Fibrosis Scores Have Good Specificity to Rule Out Advanced Fibrosis in Healthy Liver Donors: A Biopsy-Based Study.
作者信息
Singh Gargi, Singh Manish, Choudhary Narendra S, Saraf Neeraj, Soin Arvinder S
机构信息
Department of Clinical Research and Studies, Medanta The Medicity Hospital, Gurugram, 122001, Haryana, India.
Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity Hospital, Gurugram, 122001, Haryana, India.
出版信息
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102585. doi: 10.1016/j.jceh.2025.102585. Epub 2025 Apr 28.
Abstract
摘要
相似文献
1
Fibrosis-4 and NAFLD Fibrosis Scores Have Good Specificity to Rule Out Advanced Fibrosis in Healthy Liver Donors: A Biopsy-Based Study.Fibrosis-4评分和非酒精性脂肪性肝病纤维化评分在排除健康肝脏供体中的重度纤维化方面具有良好的特异性：一项基于活检的研究
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102585. doi: 10.1016/j.jceh.2025.102585. Epub 2025 Apr 28.
2
A Validation Study of Non-invasive Scoring Systems for Assessing Severity of Hepatic Fibrosis in a Cohort of South Indian Patients With Non-alcoholic Fatty Liver Disease.一项针对南印度非酒精性脂肪性肝病患者队列评估肝纤维化严重程度的非侵入性评分系统的验证研究。
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101407. doi: 10.1016/j.jceh.2024.101407. Epub 2024 Apr 5.
3
Liver fibrosis stage based on the four factors (FIB-4) score or Forns index in adults with chronic hepatitis C.基于四项因素（FIB-4）评分或 Forns 指数的成人慢性丙型肝炎肝纤维化分期。
Cochrane Database Syst Rev. 2024 Aug 13;8(8):CD011929. doi: 10.1002/14651858.CD011929.pub2.
4
Diagnostic performance of a new algorithm combining simple, non-invasive and inexpensive tests for predicting the presence of advanced liver fibrosis in patients with chronic hepatitis B.一种结合简单、无创且廉价检测方法的新算法对预测慢性乙型肝炎患者是否存在晚期肝纤维化的诊断性能。
BMC Gastroenterol. 2025 Jul 1;25(1):447. doi: 10.1186/s12876-025-03857-4.
5
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.当前非酒精性脂肪性肝病管理指南：系统评价与比较分析。
World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361.
6
Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis.非酒精性脂肪性肝病中的肝细胞癌和肝外癌症：系统评价和荟萃分析。
Eur J Cancer. 2022 Sep;173:250-262. doi: 10.1016/j.ejca.2022.06.051. Epub 2022 Aug 6.
7
Algorithmic screening of advanced liver fibrosis in a high-risk population and correlation with transient elastography results.高危人群中晚期肝纤维化的算法筛查及其与瞬时弹性成像结果的相关性。
J Investig Med. 2025 May 8:10815589251342189. doi: 10.1177/10815589251342189.
8
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.胰岛素增敏剂治疗非酒精性脂肪性肝病：系统评价。
Health Technol Assess. 2011 Nov;15(38):1-110. doi: 10.3310/hta15380.
9
Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis.磁共振弹性成像用于非酒精性脂肪性肝病肝纤维化分期：诊断准确性的系统评价和个体参与者数据汇总分析
Eur Radiol. 2016 May;26(5):1431-40. doi: 10.1007/s00330-015-3949-z. Epub 2015 Aug 28.
10
Disease State Transition Probabilities Across the Spectrum of NAFLD: A Systematic Review and Meta-Analysis of Paired Biopsy or Imaging Studies.非酒精性脂肪性肝病（NAFLD）各阶段疾病状态转变概率：配对肝活检或影像学研究的系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 May;21(5):1154-1168. doi: 10.1016/j.cgh.2022.07.033. Epub 2022 Aug 4.
本文引用的文献
1
Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort.非酒精性脂肪性肝病（NAFLD）与代谢相关脂肪性肝病（MASLD）之间存在显著重叠，疾病严重程度和非侵入性检测性能相当：对印度MASLD联盟（ICOM-D）队列的分析
J Hepatol. 2024 Oct;81(4):e162-e164. doi: 10.1016/j.jhep.2024.05.027. Epub 2024 May 25.
2
Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.非酒精性脂肪性肝病患者中晚期纤维化无创检测的性能不佳：一项多中心亚洲研究。
Dig Dis Sci. 2023 Dec;68(12):4485-4498. doi: 10.1007/s10620-023-08085-y. Epub 2023 Sep 21.
3
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会（INASL）关于非酒精性脂肪性肝病（NAFLD）命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
4
Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.印度非酒精性脂肪性肝病的患病率：一项系统评价与荟萃分析。
J Clin Exp Hepatol. 2022 May-Jun;12(3):818-829. doi: 10.1016/j.jceh.2021.11.010. Epub 2021 Nov 25.
5
Spotlight on Impactful Research: Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systemic Review and Meta-Analysis.聚焦有影响力的研究：非酒精性脂肪性肝病中纤维化阶段导致的死亡风险增加：系统评价与荟萃分析
Clin Liver Dis (Hoboken). 2018 Sep 7;12(2):35-38. doi: 10.1002/cld.726. eCollection 2018 Aug.
6
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.比较实验室检查、超声或磁共振弹性成像在非酒精性脂肪性肝病患者中检测纤维化的价值：一项荟萃分析。
Hepatology. 2017 Nov;66(5):1486-1501. doi: 10.1002/hep.29302. Epub 2017 Sep 26.
7
Prediction of nonalcoholic fatty liver in prospective liver donors.前瞻性肝脏供体中非酒精性脂肪肝的预测
Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12890. Epub 2017 Feb 13.
8
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.非酒精性脂肪性肝病纤维化评分：一种用于识别非酒精性脂肪性肝病患者肝纤维化的非侵入性系统。
Hepatology. 2007 Apr;45(4):846-54. doi: 10.1002/hep.21496.
9
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.开发一种简单的非侵入性指标以预测HIV/HCV合并感染患者的显著纤维化。
Hepatology. 2006 Jun;43(6):1317-25. doi: 10.1002/hep.21178.
Zotero 插件